Petosemtamab (FUT8-KO) Antibody
Petosemtamab (FUT8-KO) is a defucosylated monoclonal antibody targeting EGFR and LGR5, disrupting oncogenic signaling and inducing receptor degradation. It is utilized in preclinical in vitro and in vivo research for solid tumors, including head and neck squamous cell carcinoma and colorectal cancer.
Product Specifications
Target
EGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940149-500 1x 500 µL
CD106 / VCAM1 (1.4C3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740774-100 1x 100 µL
HSP27 (HSPB1/774), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042782-500 1x 500 µL
Calbindin 1 (CALB1) (CALB1/2782), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471602-100 1x 100 µL
CD56 / NCAM1 / NKH1 (Neuronal Cell Marker) (ERIC-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details